​

Gyre Therapeutics (GYRE) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Gyre Therapeutics Revenue Highlights

Latest Revenue (Y)

$105.76M

Latest Revenue (Q)

$25.49M

Main Segment (Y)

Product

Gyre Therapeutics Revenue by Period

Gyre Therapeutics Revenue by Year

DateRevenueChange
2024-12-31$105.76M-6.78%
2023-12-31$113.45M14188.41%
2022-12-31$794.00K-89.18%
2021-12-31$7.34M-64.97%
2020-12-31$20.95M100.00%
2019-12-31--100.00%
2018-12-31$6.00K-99.41%
2017-12-31$1.02M155.14%
2016-12-31$399.00K-77.20%
2015-12-31$1.75M536.36%
2014-12-31$275.00K-92.42%
2013-12-31$3.63M-93.73%
2012-12-31$57.86M-40.74%
2011-12-31$97.64M13.91%
2010-12-31$85.71M242.00%
2009-12-31$25.06M24.78%
2008-12-31$20.09M73.51%
2007-12-31$11.58M-57.96%
2006-12-31$27.54M2233.86%
2005-12-31$1.18M-68.44%
2004-12-31$3.74M52.09%
2003-12-31$2.46M7.52%
2002-12-31$2.29M34.23%
2001-12-31$1.70M-

Gyre Therapeutics generated $105.76M in revenue during NA 2024, up -6.78% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Gyre Therapeutics Revenue by Quarter

DateRevenueChange
2024-09-30$25.49M1.04%
2024-06-30$25.23M-7.17%
2024-03-31$27.17M-9.37%
2023-12-31$29.98M-2.45%
2023-09-30$30.74M17.60%
2023-06-30$26.14M6.95%
2023-03-31$24.44M-3177.74%
2022-12-31$-794.00K-102.72%
2022-09-30$29.17M25.02%
2022-06-30$23.33M2838.68%
2022-03-31$794.00K-67.46%
2021-12-31$2.44M6.13%
2021-09-30$2.30M103.09%
2021-06-30$1.13M-22.84%
2021-03-31$1.47M-27.77%
2020-12-31$2.03M127.44%
2020-09-30$893.00K-46.14%
2020-06-30$1.66M-89.87%
2020-03-31$16.37M100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31--100.00%
2018-12-31$-6.00K100.00%
2018-09-30-100.00%
2018-06-30--100.00%
2018-03-31$6.00K-98.11%
2017-12-31$318.00K-
2017-09-30$318.00K186.49%
2017-06-30$111.00K-59.04%
2017-03-31$271.00K281.69%
2016-12-31$71.00K-34.86%
2016-09-30$109.00K-

Gyre Therapeutics generated $25.49M in revenue during Q3 2024, up 1.04% compared to the previous quarter, and up 97.52% compared to the same period a year ago.

Gyre Therapeutics Revenue Breakdown

Gyre Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24
Product$105.80M

Gyre Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 24: Product (100.00%).

Quarterly Revenue by Product

Product/ServiceDec 24Sep 24Jun 24
Product$55.10M$25.50M$25.20M

Gyre Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: Product (100.00%).

GYRE Revenue FAQ

What is Gyre Therapeutics’s yearly revenue?

Gyre Therapeutics's yearly revenue for 2024 was $105.76M, representing a decrease of -6.78% compared to 2023. The company's yearly revenue for 2023 was $113.45M, representing an increase of 14188.41% compared to 2022. GYRE's yearly revenue for 2022 was $794K, representing a decrease of -89.18% compared to 2021.

What is Gyre Therapeutics’s quarterly revenue?

Gyre Therapeutics's quarterly revenue for Q3 2024 was $25.49M, a 1.04% increase from the previous quarter (Q2 2024), and a -17.07% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $25.22M, a -7.17% decrease from the previous quarter (Q1 2024), and a -3.48% decrease year-over-year (Q2 2023). GYRE's quarterly revenue for Q1 2024 was $27.17M, a -9.37% decrease from the previous quarter (Q4 2023), and a 11.19% increase year-over-year (Q1 2023).

What is Gyre Therapeutics’s revenue growth rate?

Gyre Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 13219.52%, and for the last 5 years (2020-2024) was 404.85%.

What are Gyre Therapeutics’s revenue streams?

Gyre Therapeutics's revenue streams in c 24 are Product

What is Gyre Therapeutics’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Gyre Therapeutics was Product. This segment made a revenue of $105.8M, representing 100.00% of the company's total revenue.